GB Sciences Inc (OTCMKTS:GBLX) insider Craig Ellins sold 100,000 shares of GB Sciences stock in a transaction that occurred on Friday, August 4th. The shares were sold at an average price of $0.26, for a total transaction of $26,000.00. Following the completion of the sale, the insider now owns 5,761,000 shares in the company, valued at $1,497,860. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

GB Sciences Inc (GBLX) traded up 1.953% during mid-day trading on Monday, hitting $0.261. 287,746 shares of the stock were exchanged. GB Sciences Inc has a 1-year low of $0.21 and a 1-year high of $0.65. The company’s market capitalization is $33.32 million. The stock has a 50 day moving average price of $0.28 and a 200 day moving average price of $0.31.

TRADEMARK VIOLATION NOTICE: This piece was first posted by American Banking News and is the sole property of of American Banking News. If you are reading this piece on another website, it was copied illegally and reposted in violation of United States & international trademark & copyright law. The original version of this piece can be accessed at https://www.americanbankingnews.com/2017/08/07/gb-sciences-inc-gblx-insider-sells-26000-00-in-stock.html.

GB Sciences Company Profile

GB Sciences, Inc, formerly Growblox Sciences, Inc, is engaged in developing and utilizing technologies in plant biology, cultivation and extraction techniques combined with biotechnology, and plans to produce medical-grade cannabis, cannabis concentrates and cannabinoid therapies. It seeks to be a technology and solution company that converts the cannabis plant into medicines, therapies and treatments for a range of ailments.

Receive News & Ratings for GB Sciences Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GB Sciences Inc and related companies with MarketBeat.com's FREE daily email newsletter.